Case

May 27, 2016

Bayer Inc. et al. v Fresenius Kabi Canada Ltd. et al.

We obtained an order preventing Fresenius from obtaining approval to market a generic version of Bayer’s AVELOX IV product until expiry of Bayer’s patent.

Bayer Inc. et al. v Fresenius Kabi Canada Ltd. et al.

Expertise

Patents

All Cases

Peter Wilcox

Partner

Direct: 416.863.3363T 416.863.3363 Fax: 416.863.9171
Email: pwilcox@belmorelaw.com

More cases featuring Peter Wilcox

Pfizer Canada Inc. v. Canada (Minister of Health)
GlaxoSmithKline Inc. v. Pharmascience Inc.
Apotex Inc. v. Sanofi-Synthelabo Canada Inc.
Varco Canada Limited v. Pason Systems Corp.
Alcon Canada Inc. v. Cobalt Pharmaceuticals Company

Case

Bayer Inc. et al. v Fresenius Kabi Canada Ltd. et al.

Expertise

Peter Wilcox

Partner

More cases featuring Peter Wilcox

(416) 863-1771

(416) 863-9171

info@belmorelaw.com